Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stage II colorectal cancer (CC)
Iveson, T Sobrero, AF Yoshino, T Sougklakos, I Ou, FS Meyers, JP Shi, Q Saunders, Mark P Labianca, R Yamanaka, T
Iveson, T
Sobrero, AF
Yoshino, T
Sougklakos, I
Ou, FS
Meyers, JP
Shi, Q
Saunders, Mark P
Labianca, R
Yamanaka, T
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Iveson T, Sobrero AF, Yoshino T, Sougklakos I, Ou F-S, Meyers JP, et al. Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stage II colorectal cancer (CC). J Clin Oncol. 2019;37(15_suppl):3501-.